62 - Bringing a Drug to Market (w/ Josh Yoder!)
62. Bringing a Drug to Market
This podcast has discussed science and impacts of scientific discovery for one year now. We haven’t yet discussed how a laboratory, university, government, or company is capable of bringing a helpful small molecule to market. How does one bring a drug to market? Is it a simple process? Let’s learn to be scientifically conversational.
General Learning Concepts
1) Discussion questions:
a. What is a drug? How does one identify a prospective drug or pharmaceutical?
b. What are conditions that must be met in order to have a drug approved for sale (at least, in the United States)? (eg. Helping people more than no treatment / versus how much it hurts)
c. Can anyone bring a drug to market? What are the limitations? Is it expensive?
d. What are the different phases of clinical trials? How often does a prospective molecule make it through the different layers of clinical trials?
e. Why is it so often that treatment of different illness is so expensive?
Definition of a drug and other terms:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=glossary.page#:~:text=
Drug review process including phases:
Cost to develop a drug and percentage success:
Trial phases including numbers of patients and typical success in each phase:
http://pharmwarthegame.blogspot.com/2018/12/clinical-trials-phases.html